19 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Conditions: Liver Cirrhosis, Biliary;   Biliary Cirrhosis, Primary
Intervention:
2 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
3 Unknown  Family Studies in Primary Biliary Cirrhosis (PBC)
Condition: Biliary Cirrhosis, Primary
Intervention:
4 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
5 Recruiting Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: abatacept
6 Unknown  Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment
7 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
8 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Other: Clinic visit;   Other: Baseline visit
9 Recruiting Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: S-adenosyl-L-methionine
10 Unknown  Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: NGM282
11 Recruiting Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis (PBC)
Interventions: Drug: Placebo Comparator;   Drug: Experimental: MBX-8025 50 mg;   Drug: Experimental: MBX-8025 200 mg
12 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cirrhosis
Interventions: Drug: LJN452;   Drug: Placebo
13 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
14 Recruiting IBAT Inhibitor A4250 for Cholestatic Pruritus
Condition: Biliary Cirrhosis, Primary
Intervention: Drug: A4250
15 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
16 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
17 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
18 Recruiting Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)
Condition: All Diagnosed Health Conditions
Intervention:
19 Unknown  Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Intervention:

Indicates status has not been verified in more than two years